載入...
BTC1.01 International survey regarding use of MGMT analyses for glioma
BACKGROUND: MGMT promotor methylation status is part of glioma diagnostics, supporting clinical decision making. Internationally different methods and cut-off levels are used to determine whether a tumor is methylated or unmethylated. Treatment decisions get unreliable, when methylation status of th...
Na minha lista:
| 發表在: | Neuro Oncol |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6144055/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.000 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|